Key result
Endothelial dysfunction markers show no significant correlation with hypertension-related cardiovascular outcomes.
Why the study?
Endothelial dysfunction contributes to vascular inflammation, oxidative stress, and structural changes in hypertension, prompting this synthesis to evaluate its association with cardiovascular outcomes in hypertensive populations.
Does endothelial dysfunction assessment predict hypertension-related cardiovascular outcomes and subclinical target-organ damage in adults with or at risk for hypertension?
Meta-Analysis (n=2,847)
Does endothelial dysfunction assessment predict hypertension-related cardiovascular outcomes and subclinical target-organ damage in adults with or at risk for hypertension?
This meta-analysis found no statistically significant pooled correlation between endothelial dysfunction markers and hypertension-related cardiovascular outcomes (r=0.09, p=0.407), indicating that routine clinical assessment of endothelial function in hypertension management remains premature given substantial methodological heterogeneity.
Answers are grounded in this paper and cite their sources.
Endothelial dysfunction markers should not guide risk stratification in hypertension; challenges prior evidence and leaves open need for standardized prospective studies.
Endothelial dysfunction plays a critical role in the development and progression of cardiovascular complications in individuals with hypertension.As a key regulator of vascular tone and homeostasis, impaired endothelial function contributes to inflammation, oxidative stress, and structural vascular changes, thereby increasing cardiovascular risk.This systematic review and meta-analysis synthesized evidence from 10 studies comprising 2,847 participants that met the inclusion criteria and evaluated the association between endothelial dysfunction and cardiovascular outcomes in hypertensive populations.Endothelial dysfunction was primarily assessed using flow-mediated dilation, with additional measures including the reactive hyperemia index, pulse wave velocity, and circulating biomarkers such as nitric oxide and endothelin-1.The meta-analysis found no statistically significant pooled correlation between endothelial dysfunction markers and hypertension-related outcomes (r=0.09,95% CI -0.09 to 0.26, p=0.407), with substantial heterogeneity across studies (I²=99.4%).While individual studies reported variable associations, the quantitative synthesis does not support endothelial dysfunction as a consistent prognostic marker in hypertensive populations at this time.The substantial heterogeneity and methodological differences across studies highlight the need for standardized assessment protocols and larger prospective studies with consistent methodology to definitively establish whether a clinically meaningful association exists.Until such evidence is available, claims regarding the clinical utility of endothelial function assessment in hypertension management remain premature.
No takes yet. Share an insight, caveat, or question.
Talha et al. (2026) conducted a meta-analysis in Hypertension and cardiovascular risk (n=2,847). Endothelial dysfunction (assessed via flow-mediated dilation, peripheral arterial tonometry, or circulating biomarkers) vs. Normotensive controls or internal comparisons based on degree of endothelial dysfunction was evaluated on Correlation between endothelial dysfunction markers and hypertension-related cardiovascular outcomes (r=0.09, 95% CI -0.09 to 0.26, p=0.407). Endothelial dysfunction markers showed no significant pooled correlation with hypertension-related outcomes across 10 studies.
Synapse has enriched 10 related papers. Consider them for comparative context: